Results for tag: "Castleman Disease Drugs"

Castleman Disease (CD) is a rare lymphoproliferative disorder that affects the lymph nodes and other organs. It is classified as a subtype of lymphoma, and is characterized by an overgrowth of lymphoid cells. Treatment for CD typically involves chemotherapy, radiation therapy, and/or immunosuppressive drugs. The Castleman Disease Drugs market is a subset of the larger Lymphoma Drugs market. It is composed of drugs used to treat CD, such as monoclonal antibodies, interferons, and corticosteroids. These drugs are used to reduce the size of lymph nodes, reduce inflammation, and suppress the immune system. Some companies in the Castleman Disease Drugs market include AbbVie, Bristol-Myers Squibb, Celgene, Gilead Sciences, and Novartis. Show Less Read more